Concepedia

2749 Avelumab (MSB0010718C), an anti-PD-L1 antibody, in patients with recurrent or refractory ovarian cancer: A phase Ib trial reporting safety and clinical activity

ML Disis, M.R. Patel, S. Pant, E.P. Hamilton, A. Craig Lockhart, Karen Kelly, J. Thaddeus-Beck, M. Gordon, Glen J. Weiss, Samuel Ejadi,

European Journal of Cancer · 2015 · 10 citations · 0 references

DOI

Concepts